Abiomed (NASDAQ: ABMD) is a pioneer and global leader in healthcare technology and innovation, with a mission of RECOVERING HEARTS AND SAVING LIVES. Founded in 1981, is focused on developing ground-breaking technologies designed to assist the life-sustaining pumping function of the failing heart.
The Company’s portfolio of products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the world’s first total replacement heart to the World’s Smallest Heart Pump, 1/100th the size of the heart with rapid and simple insertion, Abiomed is dedicated to finding ways to bring the most advanced and beneficial technology to patients and physicians.
For additional information, please visit: www.abiomed.com
ACC.21 Learning Pathways? (select all that apply) Heart Failure and Cardiomyopathies, Interventional Cardiology